RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies (EpAbs) vs saline placebo
All‐cause mortality (by day 28) · individuals with moderate or severe COVID‐19
RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies… showed no clear difference in all‐cause mortality (by day 28) compared with saline placebo (low certainty).
1 finding from 1 review
- RR 0.6 [0.26, 1.37]1 study · 241 participantsLow